In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma

Cancer

Volumn 86, Issue 3, 1999, Pages 391-397

  Niv, Yaron ^a,e   Sperber, Ami D ^b   Figer, Arie ^a   Igael, Dror ^c   Shany, Shraga ^b   Fraser, Gerald ^a   Schwartz, Betti ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e RABIN MEDICAL CENTER   (Israel)

Author keywords

1,25(OH)2D3; 25 OH D3; Chemoprevention; Parathyroid hormone; Proliferation

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DERIVATIVE;

ARTICLE; CALCIUM INTAKE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

AGED; CALCIFEDIOL; CALCITRIOL; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PARATHYROID HORMONE; RECTAL NEOPLASMS;

EID: 0033178979     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990801)86:3<391::AID-CNCR5>3.0.CO;2-A     Document Type: Article

References (50)

1. Holick MF, Krane SM, Potts JT Jr. Calcium, phosphorus and bone metabolism: calcium regulating hormones. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's principles of internal medicine. 13th edition. New York: McGraw-Hill, Inc., 1994.
2. Belleli A, Shany A, Levy J, Guberman R, Lamprecht SA. A protective role for 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis. Carcinogenesis 1992;13: 2293-8.
3. Meggouh F, Lointier P, Saez S. Sex steroid and 1,25-hydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res 1991;51:1227-33.
4. Binderup L, Bramm E. Effects of novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro. Biochem Pharmacol 1988;37:889-95.
5. Binderup L, Latini S, Binderup E, Bretting C, Calverley M, Hansen K. 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 1991;42:1569-75.
6. Kane KF, Langman MJS, Williams GR. Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differentially modified by 9-cis-retinoic acid. Cancer Res 1996;56:623-32.
7. Bikle DD. Chemical counterpoint: vitamin D: new action, new analogs, new therapeutic potential. Endocrinol Rev 1992;13:765-82.
8. Peehl DM, Skowronski ERJ, Leung GK, Wong ST, Stamey TA, Feldman D. Antiproliferative effects of 1,25-dihydroxy D3 on primary cultures of human prostatic cells. Cancer Res 1994; 54:805-10.
9. Mathiasen IS, Colston KW, Binderup L. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol 1993;46:365-71.
10. Brown G, Bunce CM, Rowlands DC, Williams GR. All-transretinoic acid and 1,25-dihydroxyvitamin D3 co-operate in vitro to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes. Leukemia 1994;8: 806-15.
11. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. Pleiotropic effects of vitamin D on osteoblast gene expression are related to proliferative and differentiated state of the bone cell phenotype: dependency on basal levels of gene expression, duration of exposure and bone matrix competency in normal rate osteoblast cultures. Endocrinology 1991;128:1496-504.
12. Shabahang M, Buras RR, Davoddi F. Growth inhibition of HT-29 human colon cancer cell by analogues of 1,25-dihydroxyvitamin D3. Cancer Res 1994;54:4057-64.
13. Thomas MG, Brown GR, Alison MR. Divergent effect of epidermal growth factor and calcipotriol on human rectal cell proliferation. Gut 1994;35:1742-6.
14. Skarosi S, Abraham C, Bissonette M, Scaglione-Sewell B, Sitrin MD, Brasitus TA. 1,25(OH)2D3 stimulates apoptosis in CaCo-2 cells [abstract]. Gastroenterology 1997;112(Suppl): A658.
15. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 1988;9:187-90.
16. Sitrin MD, Halline AG, Abrahams C, Brasitus TA. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res 1991; 51:5608-13.
17. Beaty MM, Lee EY, Glauret HP. Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. J Nutr 1993;123:144-52.
18. Eisman IA, Barkla DH, Tutton PJM. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 1987;47:21-5.
19. Garland CF, Shekelle RB, Barrett-Connor E, Crique RB, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;1:307-9.
20. Garland CF, Comstock GW, Garland FC, Felsing K, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight year prospective study. Lancet 1989;2:1176-8.
21. Thomas MG, Tebbutt S, Williamson RCN. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and colon cancer cell line. Gut 1992;33:1660-3.
22. Bosick RM, Potter JD, Selleres TA, McKenzie DR, Kushi LH, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women: the Iowa Women's Health Study. Am J Epidemiol 1993;137: 1302-17.
23. Potter JD, Slattery ML, Bosick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15: 499-545.
24. American Joint Committee on Cancer. Manual for staging of cancer. 4th edition. Philadelphia: J. B. Lippincott, 1992.
25. Adams JS, Singer FR, Gacad MA, Sharma OP, Hayes MJ, Vouros P, et al. Isolation and structural Identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985; 60:960-6.
26. Shany S, Rapoport J, Zuili I, Yankowitz N, Chaimovitz C. Enhancement of 24,25-dihydorxyvitamin D levels in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1986;42:141-5.
27. Reinhardt TA, Horst RL, Orf JW, Hollis BW. A microassay of 1,25(OH)2D3 not requiring HPLC. Applications to clinical studies. J Clin Endocrinol Metab 1984;58:91-8.
28. Hackeng WH, Lips L. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoradioactive PTH in normal subjects and hyper-parathyroid patients. J Clin Endocrinol Metab 1986;63:447-53.
29. Krishnan K, Brenner DE. Chemoprevention of colorectal cancer. Gastroenterol Clin North Am 1996;25:821-58.
30. Kahn MJ, Morrison DG. Chemoprevention for colorectal cancer. Hematol Oncol Clin North Am 1997;11:779-94.
31. Mettlin C. Chemoprevention: will it work? Int J Cancer 1997; 10(Supplement):18-21.
32. Brasitus TA. Primary chemoprevention strategies for colorectal cancer: ursodeoxycholic acid and other agents. Gastroenterology 1995;109:2036-8.
33. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Cancer 1992;70:2861-9.
34. Faivre J, Couillault C, Kronborg O, Rath U, Giacosa A, De Oliveira H, et al. Chemoprevention of metachronous adenomas of the large bowel: design and interim results of a randomized trial of calcium and fibre. ECP Colon Group. Eur J Cancer Prev 1997;6:132-8.
35. LaVecchia C, Braga C, Begri E, Franceschi S, Russo A, Conti E, et al. Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 1997;73:525-30.
36. Glinghammar B, Venturi M, Rowland IR, Rafter JJ. Shift from a dairy product-rich to a dairy product-free diet: influence on cytotoxicity and genotoxicity of fecal water-potential risk factors for colon cancer. Am J Clin Nutr 1997;66:1277-82.
37. White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 1997;6:769-74.
38. van Poppel G, van den Berg H. Vitamins and cancer. Cancer Lett 1997;114:195-202.
39. Pritchard RS, Baron JA, Gerhardsson de Verdier M. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 1996;5:897-900.
40. Martinez ME, Giovannucci EL, Colditz GA, Stampfer MJ, Hunter DJ, Speizer FE, et al. Calcium vitamin D, and dairy foods and the occurrence of colon cancer among women. J Natl Cancer Inst 1996;88:1375-82.
41. Kearney J, Giavannucci EL, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium, vitamin D, dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996;143:907-17.
42. Chritakos S, Raval-Pandya M, Werney RP, Yang W. Genomic mechanisms involved in the pleiotropic actions of 1,25-hydroxyvitamin D3. Biochem J 1996;316:361-71.
43. Cross HS, Bajna E, Bises G, Genser D, Kallay E, Potzi R, et al. Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res 1996;16:2333-7.
44. Evans RM. The steroid and thyroid hormone receptor super family. Science 1988;240:889-95.
45. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature 1992;355:446-9.
46. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, et al. RXR-b: a coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 1991;67:1251-66.
47. Cheskis B, Freedman LP. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol Cell Biol 1994; 14:3329-38.
48. Williams GR. Solving the specificity puzzle. Nature 1994;370: 330-1.
49. Schrader M, Nayeri S, Kahlen JP, Muller KM, Carlberg C. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol Cell Biol 1995;15:1154-61.
50. Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, et al. Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology 1996;110:1605-13.